This compound is a fluorinated nitroquinazoline derivative used as a pharmaceutical intermediate in the manufacturing of afatinib impurities. Its structure features multiple halogen and amine functional groups, contributing to its role in research and development.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2226537-61-5
N-(4-Chloro-3-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
pharmaceutical intermediate
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for drug synthesis
N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
impurity reference standard for afatinib
(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
Pharmaceutical intermediate for afatinib impurities
(R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine
Pharmaceutical intermediate for afatinib impurities
2-Bromo-5-(4-cyanophenoxy)benzyl acetate
Pharmaceutical intermediate
Methyl 4-[(1S)-1-aminoethyl]benzoate
pharmaceutical intermediate
(R)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol
Pharmaceutical intermediate for synthesis
N-(3,4-difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
DZRYHCITHKPDFS-UHFFFAOYSA-N
C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F)F)F
—